113 related articles for article (PubMed ID: 34607625)
1. Risk factors of sudden unexpected death in patients with advanced cancer near the end of life.
Taniyama T; Tokutani R; Hiramoto S
Palliat Support Care; 2022 Dec; 20(6):818-822. PubMed ID: 34607625
[TBL] [Abstract][Full Text] [Related]
2. Effects of molecular targeting agents and immune-checkpoint inhibitors in patients with advanced cancer who are near the end of life.
Hiramoto S; Taniyama T; Kikuchi A; Hori T; Yoshioka A; Inoue A
Palliat Support Care; 2021 Dec; 19(6):709-714. PubMed ID: 33729120
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer.
Hiramoto S; Tamaki T; Nagashima K; Hori T; Kikuchi A; Yoshioka A; Inoue A
Int J Clin Oncol; 2019 Apr; 24(4):454-459. PubMed ID: 30377853
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer.
Kapadia NS; Mamet R; Zornosa C; Niland JC; D'Amico TA; Hayman JA
Cancer; 2012 Sep; 118(17):4339-45. PubMed ID: 22252390
[TBL] [Abstract][Full Text] [Related]
5. End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysis.
Allen MJ; Dunn N; Guan T; Harrington J; Walpole E
Intern Med J; 2022 Apr; 52(4):623-632. PubMed ID: 33070428
[TBL] [Abstract][Full Text] [Related]
6. Associations Among End-of-Life Discussions, Health-Care Utilization, and Costs in Persons With Advanced Cancer: A Systematic Review.
Starr LT; Ulrich CM; Corey KL; Meghani SH
Am J Hosp Palliat Care; 2019 Oct; 36(10):913-926. PubMed ID: 31072109
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the initiation of chemotherapy within 90 days of death in metastatic colorectal cancer patients: a population-based study.
Batra A; McKinnon G; Billawala A; Sheka D; Kong S; Cheung WY
Support Care Cancer; 2021 Mar; 29(3):1535-1542. PubMed ID: 32725376
[TBL] [Abstract][Full Text] [Related]
8. End-of-life care discussions among patients with advanced cancer: a cohort study.
Mack JW; Cronin A; Taback N; Huskamp HA; Keating NL; Malin JL; Earle CC; Weeks JC
Ann Intern Med; 2012 Feb; 156(3):204-10. PubMed ID: 22312140
[TBL] [Abstract][Full Text] [Related]
9. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.
Bükki J; Scherbel J; Stiel S; Klein C; Meidenbauer N; Ostgathe C
Support Care Cancer; 2013 Jun; 21(6):1743-50. PubMed ID: 23344656
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Advance Care Planning and End-of-life Communication for Patients with Advanced and Metastatic Breast Cancer.
Sagara Y; Mori M; Yamamoto S; Eguchi K; Iwatani T; Naito Y; Kogawa T; Tanaka K; Kotani H; Yasojima H; Ozaki Y; Noguchi E; Miyasita M; Kondo N; Niikura N; Toi M; Shien T; Iwata H
Oncologist; 2021 Apr; 26(4):e686-e693. PubMed ID: 33321004
[TBL] [Abstract][Full Text] [Related]
11. Determinants for aggressive end-of-life care for oral cancer patients: a population-based study in an Asian country.
Chang TS; Su YC; Lee CC
Medicine (Baltimore); 2015 Jan; 94(4):e460. PubMed ID: 25634186
[TBL] [Abstract][Full Text] [Related]
12. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
13. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
Chen ML; Chen YY; Tang ST
Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
[TBL] [Abstract][Full Text] [Related]
15. Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer.
Liang YH; Wei CH; Hsu WH; Shao YY; Lin YC; Chou PC; Cheng AL; Yeh KH
Support Care Cancer; 2017 Feb; 25(2):533-539. PubMed ID: 27704261
[TBL] [Abstract][Full Text] [Related]
16. Changes of End of Life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study.
Jho HJ; Nam EJ; Shin IW; Kim SY
Cancer Res Treat; 2020 Apr; 52(2):419-425. PubMed ID: 31476847
[TBL] [Abstract][Full Text] [Related]
17. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
18. Provision of spiritual support to patients with advanced cancer by religious communities and associations with medical care at the end of life.
Balboni TA; Balboni M; Enzinger AC; Gallivan K; Paulk ME; Wright A; Steinhauser K; VanderWeele TJ; Prigerson HG
JAMA Intern Med; 2013 Jun; 173(12):1109-17. PubMed ID: 23649656
[TBL] [Abstract][Full Text] [Related]
19. End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting.
Canavan M; Wang X; Ascha M; Miksad R; Showalter TN; Calip G; Gross CP; Adelson K
J Clin Oncol; 2023 Oct; 41(30):4729-4738. PubMed ID: 37339389
[TBL] [Abstract][Full Text] [Related]
20. High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: A population-based study from the French national hospital database.
Revon-Rivière G; Pauly V; Baumstarck K; Bernard C; André N; Gentet JC; Seyler C; Fond G; Orleans V; Michel G; Auquier P; Boyer L
Cancer; 2019 Jul; 125(13):2300-2308. PubMed ID: 30913309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
